Tag: clinical trial
Beta Blockers After Heart Attack Show No Benefit in Major International Study
A major international study of over 5,000 patients found beta blockers provide no benefit after uncomplicated heart attacks, with women…
Survodutide Weekly Injection Shows 17.5% Weight Loss in Phase 3 Obesity Trial
Phase 3 trial shows survodutide weekly injection achieved 17.5% weight loss versus 1.2% placebo in over 3,400 adults with obesity.…
Finerenone Shows Cardiovascular Benefits in Non-Diabetic Chronic Kidney Disease Patients
Finerenone significantly reduces cardiovascular events by 14% in non-diabetic chronic kidney disease patients, according to landmark NEJM trial. The drug…
Breakthrough Drug Targeting ‘Undruggable’ KRAS Mutation Nearly Doubles Pancreatic Cancer Survival
New targeted therapy daraxonrasib successfully inhibits KRAS mutations in pancreatic cancer, nearly doubling survival times. Clinical trial shows 60% reduction…
Oral GLP-1 Drug Achieves 11.3% Weight Loss in Phase 2 Trial
Phase 2b trial shows oral GLP-1 drug aleniglipron achieved 11.3% weight loss in 230 adults with obesity. Results suggest oral…
Tomato-Soy Juice Blend Reduces Obesity-Related Inflammation in Clinical Trial
A clinical trial shows that a specially formulated tomato-soy juice reduced obesity-related inflammatory markers by up to 23% in just…
Teclistamab Shows Strong Response Rates in Earlier-Line Multiple Myeloma Treatment
Phase 3 trial shows teclistamab extends progression-free survival by 7.3 months compared with standard treatments in multiple myeloma patients with…
Breakthrough CAR T Therapy Enables Kidney Transplants for High-Antibody Patients
Breakthrough CAR T-cell therapy enables two highly sensitized kidney patients to receive transplants after reducing harmful antibodies. The experimental treatment…